I’ve been doing this long enough to recognize the exact moment symptoms stop being one problem and start being four problems, all of them leading back to the same root cause. That’s exactly what CKM syndrome is – the new cardiovascular kidney metabolic syndrome, collectively approved by four major medical organizations. If you’ve got a patient with worsening blood sugar levels, elevated blood pressure, and kidney markers that are a little off, and you’ve been treating each symptom like its own separate project, this is why your progress might be stalled. 

The heart, the kidneys, the fat cells, and the metabolic system are one connected machine, not four filing cabinets, according to conventional medicine. There are five specific stages, from a patient whose health is on point, to one whose heart, kidneys, and metabolism are all struggling.  I walk through the CKM staging, the markers worth tracking, and the five blind spots that keep good clinicians treating symptoms instead of the actual pattern. Watch the full breakdown below.

 

 

What Is CKM Syndrome?

 

CKM syndrome stands for cardiovascular kidney metabolic syndrome, and it’s the new guideline issued by the American Heart Association, the American College of Cardiology, the American Diabetes Association, and the American Society of Nephrology. Modern medicine is now saying what we’ve known for many years – that individual body systems do not work independently from one another. These four organizations don’t usually see eye to eye with functional medicine, but on this one, they beat us to it. They created an actual staging system around it.

The cardiovascular system, the kidneys, the fat cells, and the metabolic system function as one interconnected system, and treating them as four separate diagnoses is exactly why so many patients never get better. That’s not a vague suggestion. It’s the entire premise of the guideline.

CKM syndrome is not the diagnosis every overweight patient automatically qualifies for. A patient can have central weight gain and metabolic dysfunction yet never develop kidney or cardiovascular disease. What this framework provides is a way to recognize when those systems are starting to talk to each other, and how to catch it before it becomes four separate crises instead of one pattern that could have been addressed sooner.

 

What Are the Five Stages of CKM Syndrome?

 

CKM syndrome has five stages, from stage zero – a genuinely healthy patient – to stage four which is where cardiovascular disease along with kidney involvement lives. Each stage provides information about what to focus on first in order to get the patient back on track. 

Stage zero is the patient with no excess adipose tissue, normal glucose, no hypertension, and no plaquing. Your job is simple – preserve what’s working and keep her out of the doctor’s office.

Stage one occurs with excess adiposity, usually abdominal, and she may be pre-diabetic without having an elevated BMI. With GLP-1 drugs in the picture, you will likely see more of what I call the “skinny-fat patients” who look thin on the outside but have less muscle and more fat than they should. Stage two is where hypertension, elevated triglycerides, and possible metabolic syndrome show up, indicating that lifestyle changes and blood sugar support are a must and hopefully, will be enough to prevent involvement with the kidneys or cardiovascular system. 

Stage three indicates subclinical cardiovascular disease, coronary calcium, plaquing, or early kidney markers like a shifting eGFR or UACR. The patient may feel completely fine despite their labs saying otherwise, and that’s the trap. Primary prevention at this stage doesn’t mean low risk, it means checking the labs before her symptoms catch up to what’s already happening in her arteries and kidneys.

Stage four is true cardiovascular disease, coronary heart disease, stroke, TIAs, atrial fibrillation, kidney dysfunction, and swelling in the legs. It has two substages. This disease as a whole is also showing up in younger patients now, largely because of what we’re feeding our kids.

 

What Lab Markers and Basics Should I Be Tracking?

 

Start by tracking waist circumference, blood pressure, glucose and A1C, triglycerides, eGFR, cystatin C, and UACR. These will tell you more about CKM syndrome progression than an expensive panel ever will. When was the last time you measured a waist circumference in your office? Elevated triglycerides are a key marker as well as they indicate what’s happening with fat deposition before the scale does.

UACR stands for urine albumin to creatinine ratio, and it tells you how the kidneys are handling protein and gives you information about vascular injury in the kidneys. Track it alongside eGFR and cystatin C as part of the same kidney picture, especially once metabolic dysfunction and hypertension are documented. Homocysteine is worth adding too – it’s a significant inflammatory marker and should be considered with any cardiovascular concerns.

You don’t need to order specialty lab testing to catch this early. Start with the basics you may already be skipping and build from there. An NMR Lipoprofile provides a more detailed lipid picture including particle size and a HOMA-IR score. This is a good addition to your baseline labs, waist circumference and blood pressure. Get the fundamentals documented before you add anything more advanced.

Once you’ve got the basics, evaluate other dominant drivers including sleep apnea, nicotine exposure, exercise tolerance, and any arterial plaquing that showed up on a Lifeline screening or other cardiovascular evaluation. The American Heart Association’s PREVENT calculator(opens in new tab) is a useful way to quantify overall risk for patients between 30 and 80. It’s not built for anyone younger, so don’t lean on it outside that range.

 

What’s the Biggest Blind Spot With CKM Syndrome?

 

The biggest blind spot for practitioners working with CKM syndrome is isolating each symptom or organ system and creating a separate protocol instead of figuring out which organ is under the most stress and starting there. When you give one or two supplements for blood sugar, another for lipids, milk thistle and inositol for the fatty liver, and something else for hypertension, it becomes chaotic and difficult to track changes. Using this new CKM staging system will allow you to target what’s most important and make a difference for the patient.

In Functional Medicine, we talk about getting to the root cause but then we silo off the symptoms into separate boxes which can defeat the purpose. The biggest blind spot isn’t a missing test or adding one more supplement, it’s resisting the urge to treat every symptom as its own separate problem when they’re part of one larger pattern. If there’s excess adipose tissue, that’s where you’ll always start – before the kidneys or the cardiovascular system, because the metabolism issue is likely driving the rest.

The same goes for working with a patient’s lifestyle while considering changes to her medications. The medication changes must be made by the prescribing physician and coordinating her care between both providers becomes essential. Medications can provide psychological safety for a patient who isn’t ready to make any changes. The last thing you want to do is make that the focus instead of helping reduce the adipose tissue and optimize diet and lifestyle.

 

Where Do I Start With a Patient Who Has This?

 

Start with the adipose tissue every time, then build a timeline that tracks her numbers over time so you and the patient can both see whether she is moving in the right direction. Fat cells function as an endocrine organ and an immune organ, so excess adiposity will drive inflammation, oxidative stress, and insulin resistance before you ever get to the kidneys or the heart. Address that first, and the cardiovascular and kidney support you layer in afterward will be much more effective. 

That same excess adiposity is also how a patient ends up with a fatty liver. What used to be called non-alcoholic fatty liver disease is now MASLD, metabolic dysfunction-associated steatotic liver disease. It shows up alongside rising triglycerides and dysregulated glucose, and it’s tied to the overall metabolic picture, not a need for more detoxification. Treat it like a metabolic problem by reducing adiposity and supporting the liver with milk thistle or other targeted support. 

Be sure to track waist circumference, blood pressure, and related blood markers including glucose, A1C, triglycerides, eGFR, and UACR at intake and reevaluate at 60-90 days. Waist circumference and blood pressure should be checked at every visit. This allows you to monitor improvement instead of relying on subjective feedback from the patient. You cannot rebuild a patient’s cardiovascular, kidney, and metabolic system in a day, so track the trajectory instead of chasing a single snapshot.

Develop a relationship with a cardiologist in your community who understands what you do, so you have somewhere to send a patient the moment you see edema, exertional intolerance, or nighttime symptoms that suggest something cardiac-related may be occurring. These types of referrals do more for your practice than you think. A cardiologist, or other medical practitioner, who trusts your judgment will refer patients back to you for the diet and lifestyle work they need.

When you’re not sure where to start, take a step back and look at the whole picture from the 5,000 foot perspective before you get lost in the numbers. Trust what your eyes see. Only you know what’s happening with the patient in front of you.

Clinical References:

• 2026 AHA/ACC/ADA/ASN CKM guideline(opens in new tab)
• AHA clinician takeaways(opens in new tab)
• AHA scientific statement on CKM physiology(opens in new tab)
• AHA PREVENT calculator(opens in new tab)

Links:

• Watch the episode(opens in new tab): I walk through every stage of CKM syndrome and exactly how to map it with every patient.
• Grab the free CKM checklist(opens in new tab) and keep a copy in every treatment room.

 

About

 

Ronda Nelson(opens in new tab), PhD, MH, is the founder of Clinical Business Academy and Clinical Academy, and host of The Clinical Entrepreneur Show. Drawing from more than 20 years of experience as a practitioner, educator, and business owner, and having trained more than 4,000 wellness practitioners, she helps them identify the operational, financial, and leadership problems that keep their practices from growing. Her work focuses on patient retention, follow-up, communication, systems, profitability, and the business structure required to build a practice that supports both excellent patient care and long-term sustainability.

 

Related Content

 

Clinical Academy(opens in new tab): Where I teach you exactly what to do next with a patient like this one, instead of handing you one more thing to learn.

The Five Non-Negotiables(opens in new tab): My free guide to the five foundational areas I check before reaching for anything more complicated than what’s already sitting in front of me.

 

Frequently Asked Questions

 

What is CKM syndrome?

 

CKM syndrome stands for cardiovascular kidney metabolic syndrome. It is a formal guideline from the American Heart Association, the American College of Cardiology, the American Diabetes Association, and the American Society of Nephrology stating that the heart, kidneys, fat tissue, and metabolic system function as one interconnected system rather than four separate conditions.

 

What are the stages of CKM syndrome?

 

CKM syndrome has five stages. Stage zero is a healthy patient with no excess adiposity or cardiovascular risk. Stages one and two involve excess adiposity, prediabetes, elevated triglycerides, and hypertension. Stage three shows subclinical cardiovascular or kidney disease. Stage four means established cardiovascular disease with kidney involvement.

 

What should I check for a patient with CKM syndrome?

 

Start with waist circumference, blood pressure, glucose and A1C, and triglycerides. Add eGFR, cystatin C, and UACR to evaluate kidney involvement, along with homocysteine as an inflammatory marker. The American Heart Association’s PREVENT calculator can help quantify overall cardiovascular risk for adults 30 to 80.

 

What is MASLD and how does it relate to CKM syndrome?

 

MASLD stands for metabolic dysfunction-associated steatotic liver disease, the updated name for what used to be called non-alcoholic fatty liver disease. It develops alongside rising triglycerides and excess adipose tissue and reflects metabolic dysfunction rather than toxin buildup, so it responds to metabolic support, not a liver detox.

 

When should I refer a CKM syndrome patient to a cardiologist?

 

Refer when you see edema in the legs, exertional intolerance, rapid weight changes, or nighttime breathing symptoms that suggest cardiac involvement. Building a relationship with a cardiologist in your community before you need one means you have somewhere reliable to send a patient the moment these signs appear.

 

Disclaimer/Disclosure

 

This content is for educational purposes only and is intended for wellness practitioners working within the functional medicine and integrative health space. This episode reflects Ronda Nelson’s personal experience and professional perspective as a practitioner, business owner, and mentor. It is not medical, mental health, legal, or financial advice. Practitioners are responsible for applying this information within their legal and professional scope. Ronda Nelson is the founder and owner of Clinical Business Academy and Clinical Academy. No sponsorship or outside compensation was received for resources mentioned in this episode.